Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Long-Term Investments (2024 - 2025)

Plus Therapeutics (PSTV) has disclosed Long-Term Investments for 6 consecutive years, with $4.6 million as the latest value for Q2 2025.

  • Quarterly Long-Term Investments changed N/A to $4.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Jun 2025, changed N/A year-over-year, with the annual reading at $3.5 million for FY2024, N/A changed from the prior year.
  • Long-Term Investments for Q2 2025 was $4.6 million at Plus Therapeutics, up from $3.5 million in the prior quarter.
  • The five-year high for Long-Term Investments was $4.6 million in Q2 2025, with the low at $772000.0 in Q1 2024.